Integrating multi-omics and artificial intelligence fuels advanced target identification and drug discovery.

Target identification is pivotal for developing novel therapeutics in cancer and other diseases. Traditional experiment screening methods are constrained by low throughput and the complexity of biological systems. Multi-omics technologies offer a tra…

Preview only. Read the full abstract at the source